Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2004
|
| gptkbp:ATCCode |
G04BD08
|
| gptkbp:contraindication |
urinary retention
uncontrolled narrow-angle glaucoma gastric retention |
| gptkbp:drugClass |
antimuscarinic
|
| gptkbp:excretion |
urine
feces |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:solifenacin
|
| gptkbp:halfLife |
45-68 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vesicare
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Astellas_Pharma
|
| gptkbp:mechanismOfAction |
muscarinic receptor antagonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision dry mouth urinary retention |
| gptkbp:usedFor |
urinary incontinence
overactive bladder urinary frequency urinary urgency |
| gptkbp:bfsParent |
gptkb:Astellas_Pharma
|
| gptkbp:bfsLayer |
5
|